論文（英文）

• Ogihara T, Nakao K, Fukui T, Fukiyama K, Ueshima K, Oba K, Sato T, Saruta T. Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks: CASE-J trial. Hypertension 2008; 51: 393-8.
• Cho H, Tsuburaya A, Sakamoto J, Morita S, Oba K, Yoshikawa T, Miyajima N; Adjuvant Exercise for General Elective Surgery (AEGES) Study Group. A randomized phase II trial of preoperative exercise to reduce operative risk in gastric cancer patients with metabolic syndrome: adjuvant exercise for general elective surgery (AEGES) study group. Jpn J Clin Oncol 2008; 38: 71-3.
• Morita S, Kaptain AA, Oba K, Sakamoto J. Domain Structure of the EORTC QLQ-STO22 Supported by Japanese Validation Data. Psychooncology 2008; 17: 474-9.
• Ogihara T, Nakao K, Fukui T, Fukiyama K, Fujimoto A, Ueshima K, Oba K, Shimamoto K, Matsuoka H, Saruta T, for the CASE-J Trial Group. The optimal target blood pressure for antihypertensive treatment in the Japanese elderly patients with high-risk hypertension: a subanalysis of CASE-J trial. Hypertens Res 2008; 31: 1595-601.
• Takeuchi Y, Uetsuka K, Murayama M, Kikuta F, Takashima A, Doi K, Nakayama H. Complementary distributions of amyloid-beta and neprilysin in the brains of dogs and cats. Vet Pathol. 2008; 45(4): 455–466.
• Yoshida S, Matsuyama Y, Ohashi Y, and Ueshima H. A Poisson mixed effects model for investigating the exposure-by-cohort interaction: A Gibbs sampling approach. Japanese Journal of Biometrics 2008; 29: 61-74.
• Yasunaga H, Matsuyama Y, Ohe K for the Japan Neurosurgical Society. Risk-adjusted analyses of the effects of hospital and surgeon volumes on postoperative complications and the modified Rankin scale after clipping of unruptured intracranial aneurysms in Japan. Neurologia Medico-Chirurgica 2008; 48: 531-538.
• Matsuyama Y and Yamaguchi T. Estimation of the marginal survival time in the presence of dependent competing risks using inverse probability of censoring widthed (IPCW) methods. /Pharmaceutical Statistics/ 2008; 7: 202-214.
• Yasunaga H, Yanaihara H, Fuji K, Matsuyama Y, Deguchi N, and Ohe K. Influence of hospital and surgeon volumes on operative time, blood loss, and perioperative complications in radical nephrectomy. /International Journal of Urology/ 2008; 15: 688-693.
• Hasegawa K, Makuuchi M, Takayama T, Kokudo N, Arii S, Okazaki M, Okita K, Omata M, Kudo M, Kojiro M, Nakanuma Y, Takayasu K, Monden M, Matsuyama Y, and Ikai I for the Liver Cancer Study Group of Japan. Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: A preliminary report of the Japanese nationwide survey. /Journal of Hepatology/ 2008; 49: 589-594.
• Uemura K, Matsuyama Y, and Ohashi Y. A modified conditional power approach for increasing the sample size based on an interim estimate of treatment difference. Japanese Journal of Biometrics 2008; 29: 19-34.
• Tateishi R, Yoshida H, Matsuyama Y, Mine N, Kondo Y, and Omata M. Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic review. Hepatology International 2008; 2: 17-30.
• Hasegawa K, Imamura H, Ijichi M, Matsuyama Y, Sano K, Sugawara Y, Kokudo N, and Makuuchi M. Inclusion of tumor markers improves thecorrelation of the Milan criteria with vascular invasion and tumor cell differentiation in patients with hepatocellular carcinoma undergoing liver resection. /Journal of Gastrointestinal Surgery/ 2008; 12(5):858-866.
• Eguchi S, Kanematsu T, Arii S, Okazaki M, Okita K, Omata M, Ikai I, Kudo M, Kojiro M, Makuuchi M, Monden M, Matsuyama Y, Nakanuma Y, Takayasu K for the Liver Cancer Study Group of Japan. Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery 2008; 143: 469-475.
• Makuuchi M, Kokudo N, Arii S, Futagawa S, Kaneko S, Kawasaki S, Matsuyama Y, Okazaki M, Okita K, Omata M, Saida Y, Takayama T, and Yamaoka Y. Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatology Research 2008 38: 37-51.
• Tanaka Y, Matsuyama Y, and Ohashi Y. for the MEGA Study Group. Estimation of treatment effect adjusting for treatment changes using the intensity score method: an application to a large primary prevention study for coronary events (MEGA study). Statistics in Medicine 2008; 27:1718-1733.
• Takeuchi Y, Ohnishi Y, Matsunaga S, Nakayama H, Uetsuka K. Intracranial meningioma with polygonal granular cell appearance in a Chihuahua. J Vet Med Sci. 2008; 70(5): 529–532.
• Sakamoto J, Hamada C, Yoshida S, Kodaira S, Yasutomi M, Kato T, Oba K, Nakazato H, Saji S, Ohashi Y. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer. Brit J Cancer 2007; 96: 1170-7.
• Kobayashi M, Oba K, Sakamoto J, Kondo K, Nagata N, Okabayashi T. Pharmacokinetic study of paclitaxel of weekly administration dose in advanced or recurrent gastric cancer patients in Japan. Gastric Cancer 2007; 10:52-7.
• Ninomiya M, Kondo K, Matsuo K, Hirabayashi N, Kojima H, Kobayashi M, Kawamura S, Ando T, Musha N, Konno H, Nagata N, Usuki H, Miyashita Y, Oba K, Morita S, Sakamoto J. Multicenter Phase II Trial of Combination Chemotherapy with Weekly Paclitaxel and 5-Fluorouracil for the Treatment of Advanced or Recurrent Gastric Carcinoma. J Chemotherapy 2007; 19:444-50.

TOP